In a prospective study, 2o healthy women (16–35 yrs.) were treated with an oral contraceptive (o,25 mg D-norgestrel, o,o5 mg ethinyl-estradiol). Derivatives of fibrinogen and fibrin were investigated before the beginning of medication, after the 1st cycle, and after the 3rd cycle. The investigations included: determination of thrombin-clottable protein, cold precipitable protein (4°C) , ethanol precipitable protein (11,5%), ethanol gelation test, protamin sulfate test, fibrin-fibrinogen degradation products in serum, and quantitation of high-and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration of the fresh patient plasmas.There was a significant increase of thrombin clottable protein (212 vs. 236 mg/dl, p<0,001) and an increase of ethanol precipitable protein (117 vs. 168 mg/dl, p<0,003). There was no change in the cold precipitable protein nor in the paracoagulation phenomena. Fibrin-fibrinogen degradation products were not elevated. By agarose gel filtration, a significant increase in soluble fibrin complexes (p<0,02) could be demonstrated; the highest concentration of the SFC elu-ted in the position of the dimers.The study confirms a low grade activation of the coagulation system even in healthy women taking a low dose estrogen containing oral contraceptive.